You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer

Article metrics

Article menu

Download PDFPDF

Research Article
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019110
Jan 2020661
Feb 202012125
Mar 202012124
Apr 2020772
May 2020171712
Jun 202013132
Jul 202016166
Aug 202012124
Sep 202019192
Oct 202019198
Nov 202014156
Dec 2020994
Jan 2021141410
Feb 2021997
Mar 2021665
Apr 202114148
May 2021131315
Jun 202113134
Jul 2021151518
Aug 2021181712
Sep 2021303017
Oct 2021171729
Nov 2021171721
Dec 202119195
Jan 202229306
Feb 202218198
Mar 2022252512
Apr 2022242610
May 2022414115
Jun 202227306
Jul 2022242612
Aug 202231328
Sep 202233338
Oct 2022333618
Nov 2022222423
Dec 202220209
Jan 202324249
Feb 202325257
Mar 2023484922
Apr 2023222216
May 2023121210
Jun 2023151510
Jul 2023141413
Aug 2023171710
Sep 2023232311
Oct 202320206
Nov 202314143
Dec 202353537
Jan 202431327
Feb 202427279
Mar 2024323534
Total10461066516